Cargando…

Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry

BACKGROUND: Testicular tumors are the most common genital neoplasms in male dogs, with Leydig cell tumors (LCT), seminomas (SEM), and Sertoli cell tumors (SCT) the most common forms. Human SEM are classified as classical (CSEM) or spermatocytic (SSEM). Intratubular germ cell neoplasia of undifferent...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohšteter, Marko, Artuković, Branka, Severin, Krešimir, Kurilj, Andrea Gudan, Beck, Ana, Šoštarić-Zuckermann, Ivan-Conrado, Grabarević, Željko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129470/
https://www.ncbi.nlm.nih.gov/pubmed/25096628
http://dx.doi.org/10.1186/s12917-014-0169-8
_version_ 1782330239672647680
author Hohšteter, Marko
Artuković, Branka
Severin, Krešimir
Kurilj, Andrea Gudan
Beck, Ana
Šoštarić-Zuckermann, Ivan-Conrado
Grabarević, Željko
author_facet Hohšteter, Marko
Artuković, Branka
Severin, Krešimir
Kurilj, Andrea Gudan
Beck, Ana
Šoštarić-Zuckermann, Ivan-Conrado
Grabarević, Željko
author_sort Hohšteter, Marko
collection PubMed
description BACKGROUND: Testicular tumors are the most common genital neoplasms in male dogs, with Leydig cell tumors (LCT), seminomas (SEM), and Sertoli cell tumors (SCT) the most common forms. Human SEM are classified as classical (CSEM) or spermatocytic (SSEM). Intratubular germ cell neoplasia of undifferentiated origin (IGCNU) is another form of human testicular tumor. The aim of this study was to verify that CSEM/SSEM classification is valid in dogs and confirm the existence of canine IGCNU. RESULTS: Testicular tumors were found in 46% of dogs at necropsy and accounted for 7% of tumors biopsied. The median age of dogs with tumors at necropsy was 10.16 years; median age at positive biopsy was 10.24 years. The most common tumors, in decreasing order, were LCT, mixed tumors, SEM and SCT at necropsy, and SEM, SCT, mixed tumors, LCT, peripheral nerve sheath tumor, and teratoma in the biopsy group. IGCNU was found in 3% of testicles at necropsy and in 3% of biopsy samples. Two dogs had testicular tumor metastasis. Expression of c-KIT was most common in SEM and seminomatous components of mixed tumors. PLAP was mostly expressed in IGCNU, SEM, teratoma, and some mixed tumors. Cytokeratin was mainly expressed in SCT. CD30 expression was low in both groups. CONCLUSIONS: The high tumor incidence at necropsy can be attributed to older age. Tumor incidence in biopsy samples, dog age, and histological classification were consistent with previous studies. The higher incidence of SEM and SCT in the biopsy group probably resulted from the obvious clinical expression of these tumor types. The low incidence of metastasis confirmed the predominance of benign tumors. Low CD30 expression confirmed the low incidence of testicular embryonal carcinoma. Cytokeratin helps differentiate stromal tumors, especially SCT, from germ cell tumors. Histology and c-KIT and PLAP expression indicate that IGCNU exists in dogs. Expression of c-KIT and PLAP confirmed that CSEM and SSEM classification is valid in dogs.
format Online
Article
Text
id pubmed-4129470
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41294702014-08-13 Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry Hohšteter, Marko Artuković, Branka Severin, Krešimir Kurilj, Andrea Gudan Beck, Ana Šoštarić-Zuckermann, Ivan-Conrado Grabarević, Željko BMC Vet Res Research Article BACKGROUND: Testicular tumors are the most common genital neoplasms in male dogs, with Leydig cell tumors (LCT), seminomas (SEM), and Sertoli cell tumors (SCT) the most common forms. Human SEM are classified as classical (CSEM) or spermatocytic (SSEM). Intratubular germ cell neoplasia of undifferentiated origin (IGCNU) is another form of human testicular tumor. The aim of this study was to verify that CSEM/SSEM classification is valid in dogs and confirm the existence of canine IGCNU. RESULTS: Testicular tumors were found in 46% of dogs at necropsy and accounted for 7% of tumors biopsied. The median age of dogs with tumors at necropsy was 10.16 years; median age at positive biopsy was 10.24 years. The most common tumors, in decreasing order, were LCT, mixed tumors, SEM and SCT at necropsy, and SEM, SCT, mixed tumors, LCT, peripheral nerve sheath tumor, and teratoma in the biopsy group. IGCNU was found in 3% of testicles at necropsy and in 3% of biopsy samples. Two dogs had testicular tumor metastasis. Expression of c-KIT was most common in SEM and seminomatous components of mixed tumors. PLAP was mostly expressed in IGCNU, SEM, teratoma, and some mixed tumors. Cytokeratin was mainly expressed in SCT. CD30 expression was low in both groups. CONCLUSIONS: The high tumor incidence at necropsy can be attributed to older age. Tumor incidence in biopsy samples, dog age, and histological classification were consistent with previous studies. The higher incidence of SEM and SCT in the biopsy group probably resulted from the obvious clinical expression of these tumor types. The low incidence of metastasis confirmed the predominance of benign tumors. Low CD30 expression confirmed the low incidence of testicular embryonal carcinoma. Cytokeratin helps differentiate stromal tumors, especially SCT, from germ cell tumors. Histology and c-KIT and PLAP expression indicate that IGCNU exists in dogs. Expression of c-KIT and PLAP confirmed that CSEM and SSEM classification is valid in dogs. BioMed Central 2014-08-06 /pmc/articles/PMC4129470/ /pubmed/25096628 http://dx.doi.org/10.1186/s12917-014-0169-8 Text en Copyright © 2014 Hohsteter et al.; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hohšteter, Marko
Artuković, Branka
Severin, Krešimir
Kurilj, Andrea Gudan
Beck, Ana
Šoštarić-Zuckermann, Ivan-Conrado
Grabarević, Željko
Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
title Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
title_full Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
title_fullStr Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
title_full_unstemmed Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
title_short Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
title_sort canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129470/
https://www.ncbi.nlm.nih.gov/pubmed/25096628
http://dx.doi.org/10.1186/s12917-014-0169-8
work_keys_str_mv AT hohstetermarko caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry
AT artukovicbranka caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry
AT severinkresimir caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry
AT kuriljandreagudan caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry
AT beckana caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry
AT sostariczuckermannivanconrado caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry
AT grabareviczeljko caninetesticulartumorstwotypesofseminomascanbedifferentiatedbyimmunohistochemistry